Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ries

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
Blood|January 15, 1993
Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimenC A Linker, C A Ries, L E Damon, et al.
Seminars in Oncology|August 1, 1993
Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an updateC A Linker, L E Damon, C A Ries, et al.
Progress in Clinical and Biological Research|January 1, 1994
High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myelomaH S Rugo, L E Damon, C A Ries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiencyG A Smith, L E Damon, H S Rugo, et al.
Journal of Cardiovascular Pharmacology|May 1, 1982
Cardiovascular effects of AR-L115 BS in conscious dogs with and without chronic congestive heart failureH Pouleur, M F Rousseau, H van Mechelen, et al.
Bone Marrow Transplantation|November 25, 1998
Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up reportC A Linker, C A Ries, L E Damon, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Treatment of refractory chronic lymphocytic leukemia with prednimustine: a phase II study using strict response criteriaD R Gandara, C B George, C A Ries, et al.
Annals of Thoracic Surgery Short Reports|April 24, 2026
The Reality of Representation: Diversity Among Moderators at a National Cardiothoracic Surgery MeetingShanique A Ries, Rajika Jindani, Justin A Olivera, et al.
Cancer Causes & Control : CCC|July 31, 1998
Evidence that childhood acute lymphoblastic leukemia is associated with an infectious agent linked to hygiene conditionsM A Smith, R Simon, H D Strickler, et al.
Genetics|March 28, 2016
Diverse Regulation of the CreA Carbon Catabolite Repressor in Aspergillus nidulansLaure N A Ries, Sarah R Beattie, Eduardo A Espeso, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Blood|January 15, 1993
Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimenC A Linker, C A Ries, L E Damon, et al.
Seminars in Oncology|August 1, 1993
Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an updateC A Linker, L E Damon, C A Ries, et al.
Progress in Clinical and Biological Research|January 1, 1994
High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myelomaH S Rugo, L E Damon, C A Ries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiencyG A Smith, L E Damon, H S Rugo, et al.
Journal of Cardiovascular Pharmacology|May 1, 1982
Cardiovascular effects of AR-L115 BS in conscious dogs with and without chronic congestive heart failureH Pouleur, M F Rousseau, H van Mechelen, et al.
Bone Marrow Transplantation|November 25, 1998
Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up reportC A Linker, C A Ries, L E Damon, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Treatment of refractory chronic lymphocytic leukemia with prednimustine: a phase II study using strict response criteriaD R Gandara, C B George, C A Ries, et al.
Annals of Thoracic Surgery Short Reports|April 24, 2026
The Reality of Representation: Diversity Among Moderators at a National Cardiothoracic Surgery MeetingShanique A Ries, Rajika Jindani, Justin A Olivera, et al.
Cancer Causes & Control : CCC|July 31, 1998
Evidence that childhood acute lymphoblastic leukemia is associated with an infectious agent linked to hygiene conditionsM A Smith, R Simon, H D Strickler, et al.
Genetics|March 28, 2016
Diverse Regulation of the CreA Carbon Catabolite Repressor in Aspergillus nidulansLaure N A Ries, Sarah R Beattie, Eduardo A Espeso, et al.
Pageof 15